Valuation: DNA X, Inc.

Market Cap 5.83M 5.11M 4.83M 4.4M 8.24M 558M 8.3M 57.78M 22.38M 285M 21.88M 21.4M 917M P/E 2024
-0.44x
P/E 2025 -0.11x
Enterprise Value 9.59M 8.41M 7.95M 7.24M 13.56M 919M 13.65M 95.09M 36.83M 470M 36M 35.22M 1.51B EV / Sales 2024
0.17x
EV / Sales 2025 -
Free-Float
65.23%
Yield 2024 *
-
Yield 2025 -
1 day-0.89%
1 week+13.15%
Current month+6.97%
1 month+21.96%
3 months-31.32%
6 months+42.36%
Current year+24.29%
1 week 3.5
Extreme 3.5015
4.48
1 month 2.86
Extreme 2.86
4.48
Current year 2.62
Extreme 2.62
7.97
1 year 2.52
Extreme 2.5211
16.97
3 years 2.52
Extreme 2.5211
192.6
5 years 2.52
Extreme 2.5211
554.4
10 years 2.52
Extreme 2.5211
32,863.47
Manager TitleAgeSince
Chief Executive Officer 63 09/02/2026
Director of Finance/CFO 64 13/07/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 63 13/11/2023
Director/Board Member 64 13/07/2022
Director/Board Member 79 13/07/2022
Date Insider Type Main position Quantity % Market Cap. Importance
09/02/26 Free

Chief Executive Officer

50,000 3.3592%
09/02/26 Free

Chief Financial Officer

35,000 2.3514%
18/07/25 Other

Director

723 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
-0.89%+13.15%-65.35%-96.82% 5.83M
+3.25%+9.39%+242.74%+316.18% 1,343B
+0.55%+0.67%-22.30%+22.60% 1.67B
+0.16%+0.31%+25.00%+188.67% 1.38B
+0.36%+5.69%-29.63%-14.08% 1.1B
-4.99%+1.06%+6.01%+132.20% 1B
-1.62%-3.04%+36.25%-1.46% 868M
-3.02%+28.49%+15.19%+163.23% 702M
+1.95%+6.09%+23.68%+11.11% 515M
-2.52%-7.01%-51.36%+45.91% 117M
Average -0.68%+6.39%+18.02%+76.75% 134.99B
Weighted average by Cap. +3.23%+13.02%+241.43%+314.86%

Financials

2024 2025
Net sales 58.3M 51.16M 48.32M 44.03M 82.42M 5.59B 83.01M 578M 224M 2.85B 219M 214M 9.17B -
Net income -33.65M -29.53M -27.89M -25.41M -47.57M -3.22B -47.91M -334M -129M -1.65B -126M -124M -5.3B -20.66M -18.13M -17.12M -15.6M -29.21M -1.98B -29.41M -205M -79.35M -1.01B -77.56M -75.88M -3.25B
Net Debt -5.34M -4.69M -4.43M -4.04M -7.55M -512M -7.61M -52.99M -20.52M -262M -20.06M -19.63M -841M 3.76M 3.3M 3.12M 2.84M 5.32M 361M 5.36M 37.31M 14.45M 184M 14.12M 13.82M 592M
Logo DNA X, Inc.
DNA X, Inc., formerly Sonim Technologies, Inc., is a digital asset management platform, building on the digital asset trading platform. The Company operates an artificial intelligence (AI) and crypto trading platform designed to automate trading strategies using machine learning technologies. It provides a digital asset trading platform that allows users to trade or swap cryptocurrencies for other cryptocurrencies or cash equivalent currencies. The Company’s DNA X trading website enables users to implement strategies to take advantage of fluctuations in relative values of cryptocurrency pairs. The platform allows users to set up automated trading strategies, monitor other traders’ trading strategies in real time, and simulate trades. The Company generates revenue from trading commissions based on the value of trades executed on its platform. It serves individual investors from around the world and supports its operations through subsidiaries located in China, Germany, and Hong Kong.
Employees
4
Date Price Change Volume
25/09/26 $3.915 -0.89% 6,728
24/09/26 $3.950 +9.42% 8,932
23/09/26 $3.610 -17.77% 24,520
22/09/26 $4.390 +8.40% 67,706
21/09/26 $4.050 +17.05% 96,214

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SONM Stock